Enronit OR

Swine
Poultry
Enrofloxacin, colistin

More efficient than the mono medications based on enrofloxacin

A synergistic directed action

The maximum effect of therapy of colibacteriosis

Low probability of resistance development

  • Description
  • Enronit OR is a complex enrofloxacin- and colistin-based drug highly effective against colibacillosis in pigs and poultry.
    Appearance: transparent, slightly opalescent yellow solution.
    Packaging: Enronit OR is packaged in 100 and 1000 mL polyethylene vials.



    Enronit OR
  • Composition
  • Composition
    1 ml Enronit OR = 100 mg enrofloxacin, 1 000 000 IU colistin
  • Pharmacological properties
  • Pharmacological properties

    A synergistic combination of enrofloxacin and colistin sulfate, the active substances of Enronit OR provides a wide range of antimicrobial activity against Gram-positive and Gram-negative microbes. The mechanism of action of enrofloxacin (a fluroquinolone derivative) is as follows: enrofloxacin inhibits the activity of gyrase (an enzyme affecting replication of DNA spiral in the bacterial cell nucleus), which allows it to disrupt protein synthesis and suppress the growth and development of Gram-positive and Gram-negative bacteria including Escherichia coli, Haemophilus spp, Pasteurella spp, Salmonella spp., Staphylococcus spp, Streptococcus spp, Clostridium perfringens, Bordetella spp, Campylobacter spp, Corynebacterium pyogenes, Pseudomonas aeruginosa, as well as Mycoplasma spp. The mechanism of action of colistin sulfate (a polypeptide antibiotic) is as follows: colistin sulfate impairs the permeability of bacterial cell walls by connecting to lypoproteins that leads to a change in the intracellular metabolism and causes death of Gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa, Klebsiella spp, Salmonella spp. and Proteus spp.
    After oral application, enrofloxacin is quickly and fully absorbed in the gastrointestinal tract and distributed among the organs and tissues of the animal; enrofloxacin is excreted mostly unchanged and partially as metabolites with feces and urine. Colistin sulfate is scarcely absorbed in the gastrointestinal tract and does not accumulate in organs and tissues. It is excreted mostly unchanged with feces.



    HIGH ANTIBACTERIAL ACTIVITY OF ENRONIT OR IN COMPARISON WITH MONO MEDICATIONS

    Энронит ОР англ.png



  • Indications
  • Indications

    A synergistic combination of enrofloxacin and colistin sulfate, the active substances of Enronit OR provides a wide range of antimicrobial activity against Gram-positive and Gram-negative microbes. The mechanism of action of enrofloxacin (a fluroquinolone derivative) is as follows: enrofloxacin inhibits the activity of gyrase (an enzyme affecting replication of DNA spiral in the bacterial cell nucleus), which allows it to disrupt protein synthesis and suppress the growth and development of Gram-positive and Gram-negative bacteria including Escherichia coli, Haemophilus spp, Pasteurella spp, Salmonella spp., Staphylococcus spp, Streptococcus spp, Clostridium perfringens, Bordetella spp, Campylobacter spp, Corynebacterium pyogenes, Pseudomonas aeruginosa, as well as Mycoplasma spp. The mechanism of action of colistin sulfate (a polypeptide antibiotic) is as follows: colistin sulfate impairs the permeability of bacterial cell walls by connecting to lypoproteins that leads to a change in the intracellular metabolism and causes death of Gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa, Klebsiella spp, Salmonella spp. and Proteus spp.
    After oral application, enrofloxacin is quickly and fully absorbed in the gastrointestinal tract and distributed among the organs and tissues of the animal; enrofloxacin is excreted mostly unchanged and partially as metabolites with feces and urine. Colistin sulfate is scarcely absorbed in the gastrointestinal tract and does not accumulate in organs and tissues. It is excreted mostly unchanged with feces.



    HIGH ANTIBACTERIAL ACTIVITY OF ENRONIT OR IN COMPARISON WITH MONO MEDICATIONS

    Энронит ОР англ.png



  • Dosage and route of administration
  • Dosage and route of administration

    For broiler stock, breeding stock and rearing stock of chickens, hens and turkeys, Enronit OR shall be added to the water container at the following daily dose: 0.5 mL per 1 L of potable water for 3-5 days; in case of salmonellosis, mixed infections and chronic forms of diseases, Enronit OR shall be administered for at least 5 days.
    During the treatment period, poultry shall only drink water that contains Enronit OR.
    For piglets, Enronit OR shall be added to the water container (in 1:1 dilution) at the following dose: 0.3 mL per 1 kg of animal weight once a day for 2-3 days. In case of severe disease, the daily dose shall be increased to 0.5 mL per 1 kg of animal weight




  • Restrictions
  • Restrictions

    Slaughter of poultry for meat is permitted not earlier than 11 days, pigs - not earlier than 14 days after the last use of the drug. Meat from animals, forcedly slaughtered before the expiry of the stated period, can be used as feed to fur animals.

  • Publications
  • Publications
  • Treatment regimen
SIMILAR GOODS
Pnevmotil. Photo

Pnevmotil

Antibacterial
composition
250 mg tilmicozin
composition
250 mg tilmicozin
Lexoflon OR. Photo

Lexoflon OR

Antibacterial
composition
150 mg levofloxacin
composition
150 mg levofloxacin
Doxylox OR. Photo

Doxylox OR

Antibacterial
composition
100 mg doxycycline
composition
100 mg doxycycline
Ditrim powder. Photo

Ditrim powder

Antibacterial
composition
100 mg sulfadimezine
20 mg trimethoprim
composition
100 mg sulfadimezine
20 mg trimethoprim

Back to the list